195 related articles for article (PubMed ID: 9121810)
1. Nimodipine fails to enhance the analgesic effect of slow release morphine in the early phases of cancer pain treatment.
Roca G; Aguilar JL; Gomar C; Mazo V; Costa J; Vidal F
Pain; 1996 Dec; 68(2-3):239-43. PubMed ID: 9121810
[TBL] [Abstract][Full Text] [Related]
2. Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study.
Santillán R; Hurlé MA; Armijo JA; de los Mozos R; Flórez J
Pain; 1998 May; 76(1-2):17-26. PubMed ID: 9696455
[TBL] [Abstract][Full Text] [Related]
3. A comparative study with oral nifedipine, intravenous nimodipine, and magnesium sulfate in postoperative analgesia.
Zarauza R; Sáez-Fernández AN; Iribarren MJ; Carrascosa F; Adame M; Fidalgo I; Monedero P
Anesth Analg; 2000 Oct; 91(4):938-43. PubMed ID: 11004053
[TBL] [Abstract][Full Text] [Related]
4. Perioperative nimodipine and postoperative analgesia.
Casey G; Nortcliffe SA; Sharpe P; Buggy DJ
Anesth Analg; 2006 Feb; 102(2):504-8. PubMed ID: 16428551
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
[TBL] [Abstract][Full Text] [Related]
6. Randomised trial of oral morphine for chronic non-cancer pain.
Moulin DE; Iezzi A; Amireh R; Sharpe WK; Boyd D; Merskey H
Lancet; 1996 Jan; 347(8995):143-7. PubMed ID: 8544547
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
[TBL] [Abstract][Full Text] [Related]
8. A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients.
Dudgeon DJ; Bruera E; Gagnon B; Watanabe SM; Allan SJ; Warr DG; MacDonald SM; Savage C; Tu D; Pater JL
J Pain Symptom Manage; 2007 Apr; 33(4):365-71. PubMed ID: 17397698
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin enhances the analgesic effect of morphine in healthy volunteers.
Eckhardt K; Ammon S; Hofmann U; Riebe A; Gugeler N; Mikus G
Anesth Analg; 2000 Jul; 91(1):185-91. PubMed ID: 10866910
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release oxycodone and morphine in cancer related pain.
Heiskanen T; Kalso E
Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
[TBL] [Abstract][Full Text] [Related]
11. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
Zuniga JR; Ibanez C; Kozacko M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
[TBL] [Abstract][Full Text] [Related]
12. Proglumide as a morphine adjunct in cancer pain management.
Bernstein ZP; Yucht S; Battista E; Lema M; Spaulding MB
J Pain Symptom Manage; 1998 May; 15(5):314-20. PubMed ID: 9654837
[TBL] [Abstract][Full Text] [Related]
13. Lack of analgesic activity of morphine-6-glucuronide after short-term intravenous administration in healthy volunteers.
Lötsch J; Kobal G; Stockmann A; Brune K; Geisslinger G
Anesthesiology; 1997 Dec; 87(6):1348-58. PubMed ID: 9416720
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: a preliminary report.
Santillán R; Maestre JM; Hurlé MA; Flórez J
Pain; 1994 Jul; 58(1):129-132. PubMed ID: 7970835
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
[TBL] [Abstract][Full Text] [Related]
16. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial.
Israel FJ; Parker G; Charles M; Reymond L
J Pain Symptom Manage; 2010 Mar; 39(3):548-54. PubMed ID: 20083373
[TBL] [Abstract][Full Text] [Related]
17. Effects of caffeine as an adjuvant to morphine in advanced cancer patients. A randomized, double-blind, placebo-controlled, crossover study.
Mercadante S; Serretta R; Casuccio A
J Pain Symptom Manage; 2001 May; 21(5):369-72. PubMed ID: 11369156
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Analgesic Effect of Magnesium and Morphine in Combination in Patients With Cancer Pain: A Comparative Randomized Double-Blind Study.
Baaklini LG; Arruda GV; Sakata RK
Am J Hosp Palliat Care; 2017 May; 34(4):353-357. PubMed ID: 26692084
[TBL] [Abstract][Full Text] [Related]
19. Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better.
Duarte Souza JF; Lajolo PP; Pinczowski H; Del Giglio A
Support Care Cancer; 2007 Nov; 15(11):1319-1323. PubMed ID: 17805582
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of once-daily dosing of a novel, prolonged-release oral morphine tablet compared with twice-daily dosing of a standard controlled-release morphine tablet in patients with cancer pain: a randomized, double-blind, exploratory crossover study.
Ridgway D; Sopata M; Burneckis A; Jespersen L; Andersen C
J Pain Symptom Manage; 2010 Apr; 39(4):712-20. PubMed ID: 20413058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
